Integrative genomic analyses identified 14-3-3 zeta as a potential molecular driver of sorafenib resistance in HCC patients - Hajduk, J; Becker, D; Heinrich, S; Czauderna, C; Castven, D; Straub, B; Grimminger, P; Galle, P; Weinmann, A; Marquardt, J (Zeitschrift für Gastroenterologie, 2021)